Search

everythinglearnresearchcommunity

for

Search:↓

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

DHCer levels in hair could be a biomarker for alopecia progression.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Metformin helps with PCOS symptoms no matter the patient's initial insulin resistance or weight.

PRP shows potential for treating female hair loss, but more research needed.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Hair proteins have weak spots in their α-helical segments.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.